Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Averett

Showing results (261-270 of 304) with videos related to

Pageof 31
Sort By:
Cancer Discovery|July 18, 2018
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 BlockadeLimo Chen, Lixia Diao, Yongbin Yang, et al.
Cancer Discovery|May 11, 2021
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell SequencingAnsam Sinjab, Guangchun Han, Warapen Treekitkarnmongkol, et al.
The New England Journal of Medicine|June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaAndreas Rosenwald, George Wright, Wing C Chan, et al.
Physical Review Letters|April 20, 2004
Parity-violating electron deuteron scattering and the proton's neutral weak axial vector form factorT M Ito, T Averett, D Barkhuff, et al.
Physical Review Letters|August 9, 2003
Cross-section measurement of charged-pion photoproduction from hydrogen and deuteriumL Y Zhu, J Arrington, T Averett, et al.
Physical Review Letters|November 13, 2008
Quark-hadron duality in neutron (3He) spin structureP Solvignon, N Liyanage, J-P Chen, et al.
Physical Review Letters|October 26, 2005
Q2 dependence of the neutron spin structure function g2(n) at low Q2K Kramer, D S Armstrong, T D Averett, et al.
Physical Review Letters|December 21, 2011
Search for a new gauge boson in electron-nucleus fixed-target scattering by the APEX experimentS Abrahamyan, Z Ahmed, K Allada, et al.
Nature Medicine|February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trialTina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine|March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trialTina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Pageof 31

Showing results (261-270 of 304) with videos related to

Sort By:
Pageof 31
Cancer Discovery|July 18, 2018
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 BlockadeLimo Chen, Lixia Diao, Yongbin Yang, et al.
Cancer Discovery|May 11, 2021
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell SequencingAnsam Sinjab, Guangchun Han, Warapen Treekitkarnmongkol, et al.
The New England Journal of Medicine|June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaAndreas Rosenwald, George Wright, Wing C Chan, et al.
Physical Review Letters|April 20, 2004
Parity-violating electron deuteron scattering and the proton's neutral weak axial vector form factorT M Ito, T Averett, D Barkhuff, et al.
Physical Review Letters|August 9, 2003
Cross-section measurement of charged-pion photoproduction from hydrogen and deuteriumL Y Zhu, J Arrington, T Averett, et al.
Physical Review Letters|November 13, 2008
Quark-hadron duality in neutron (3He) spin structureP Solvignon, N Liyanage, J-P Chen, et al.
Physical Review Letters|October 26, 2005
Q2 dependence of the neutron spin structure function g2(n) at low Q2K Kramer, D S Armstrong, T D Averett, et al.
Physical Review Letters|December 21, 2011
Search for a new gauge boson in electron-nucleus fixed-target scattering by the APEX experimentS Abrahamyan, Z Ahmed, K Allada, et al.
Nature Medicine|February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trialTina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine|March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trialTina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Pageof 31